News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|April 5, 2022

Dr. Amy Paller discusses long-term safety and efficacy of ixekizumab in kids

Author(s)Miranda Hester

Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Dr. Paller discusses the findings of the clinical trial discussing the long-term effects of ixekizumab for treating psoriasis in children.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

ByJoshua Fitch, Senior Editor ,Jonathan Strober, MD

November 26th 2025

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

ByDruhan Howell, MD

November 25th 2025

Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults | Image credit: Contemporary Pediatrics

Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

ByJoshua Fitch, Senior Editor

November 25th 2025

FDA grants 510(k) clearance for Clarity algorithm to detect electrographic seizures in newborns | Image credit: Contemporary Pediatrics

FDA grants 510(k) clearance for Clarity algorithm to detect electrographic seizures in newborns

ByJoshua Fitch, Senior Editor

November 24th 2025

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

ByGeorge M. Rodgers, III, MD, PhD

November 22nd 2025

Latest CME

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Parents weigh holiday traditions against COVID-19 risks, national poll shows

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

How to handle picky eating at the Thanksgiving table

Eye spy: A case of a corneal lesion in an 8-year-old girl

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

© 2025 MJH Life Sciences^®

All rights reserved.